Table 1.
Baseline characteristics of the study population
| Mean (SD)a | Number of men, n = 7174 (% of total) | |
|---|---|---|
| Age (years) | 51.5±2.3 | |
| S-cholesterol levels | ||
| <5.0 mmol/L | 6.5±1.1 | 703 (9.8) |
| 5.0–5.9 mmol/L | 1986 (27.7) | |
| 6.0–6.9 mmol/L | 2364 (32.9) | |
| ≥7.0 mmol/L | 2121 (29.6) | |
| SBP | ||
| <140 mmHg | 148.5±21.8 | 2552 (35.6) |
| 140–159 mmHg | 2573 (35.9) | |
| ≥160 mmHg | 2049 (28.6) | |
| Smoking habits | ||
| Non-smoker | 3577 (49.9) | |
| Smoker | 3597 (50.1) | |
| Hypertension | ||
| Non-hypertensive | 2171 (30.3) | |
| Hypertensive | 5003 (69.7) | |
| Antihypertensive medication | 367 (5.1) | |
| Risk groupsb | ||
| Optimal risk | 130 (1.8) | |
| Low risk | 842 (11.7) | |
| Moderate risk | 2867 (40.0) | |
| Elevated risk | 2645 (36.9) | |
| High risk | 690 (9.6) | |
aSD, standard deviation.
bOptimal risk: SBP ≤140 mmHg without antihypertensive treatment, s-cholesterol <5.0 mmol and non-smoker; low risk: SBP = 140–159.9 mmHg without antihypertensive treatment, s- cholesterol 5.0–5.59 mmol, and non-smoker; moderate risk: SBP ≥160 mmHg or antihypertensive treatment or s-cholesterol ≥6.0 mmol/L or current smoker; elevated risk: SBP ≥160 mmHg or antihypertensive treatment and/or s-cholesterol ≥6.0 mmol/L, and/or current smoker; high risk: SBP ≥160 or antihypertensive treatment and s-cholesterol ≥6.0 mmol/L, and current smoker or diabetic.